In a recent study, researchers at the University of California, San Diego, have provided new insights into the central role ...

Researchers reveal that metabolic enzymes known for their roles in energy production and nucleotide synthesis are taking on unexpected 'second jobs' within the nucleus, orchestrating critical ...

Scientists at Pohang University of Science and Technology (POSTECH) and ShanghaiTech University have achieved a breakthrough ...

Merck KGaA’s $70 million bet on a treatment for a rare, locally aggressive cancer has delivered a phase 3 win. The ...

The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.

Blocking a protein that imports lactic acid, a metabolic byproduct of cancer cells, reinvigorated exhausted T cells and led to improved tumor control in mouse models of cancer, according to a new ...

Targeting and customizing blood vessels in tumors to increase T cell infiltration and maintain their function may represent the next breakthrough in cancer therapy.

The development of CAR-T technology in recent years has been a major milestone in the fight against cancer. These sort of ...

Andrew is CNET's go-to guy for product coverage and lead photographer for Europe. When not testing the latest phones, he can normally be found with his camera in hand, behind his drums or eating ...

For years, T-Mobile has been the third-largest US carrier, and the Sprint merger only solidified its position. These days T-Mobile is every bit as important as Verizon and AT&T, arguably more so ...

AT&T has played second fiddle to Verizon for a while now, but even T-Mobile is frequently starting to outshine it. Should you make the swap to T-Mobile, or AT&T the better fit? Let’s place AT&T ...